| Literature DB >> 23776599 |
Duyen Thi Kim Nguyen1, Karen K Leung, Lynn McIntyre, William A Ghali, Reg Sauve.
Abstract
BACKGROUND: An estimated 6.9 million children die annually in low and middle-income countries because of treatable illneses including pneumonia, diarrhea, and malaria. To reduce morbidity and mortality, the Integrated Management of Childhood Illness strategy was developed, which included a component to strengthen the skills of health workers in identifying and managing these conditions. A systematic review and meta-analysis were conducted to determine whether IMCI training actually improves performance.Entities:
Mesh:
Year: 2013 PMID: 23776599 PMCID: PMC3680429 DOI: 10.1371/journal.pone.0066030
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1PRISMA flowchart.
Percentages of each task performed correctly by IMCI and non-IMCI trained health workers.
| Author (Year) | Classification | Medication | Vaccination | Nutrition | Caregiver Instruction | ||||||||||
| IMCI | Non-IMCI | p | IMCI | Non-IMCI | p | IMCI | Non-IMCI | p | IMCI | Non-IMCI | p | IMCI | Non-IMCI | p | |
|
|
|
|
|
|
|
|
|
|
| ||||||
| Amaral (2004) | 65 (294) | 31 (358) | <0.001 | 67 (33) | 51 (35) | 0.57 | 39 (96) | 38 (105) | 0.26 | 55 (291) | 33 (357) | <0.001 | 57 (68) | 25 (102) | 0.002 |
| Arifeen (2009) | 64 (170) | 2 (127) | <0.001 | 78 (85) | 2 (44) | <0.001 | – | – | – | 67 (169) | 0 (123) | <0.001 | 81 (95) | 3 (98) | <0.001 |
| Armstrong (2004) | 63 (219) | 38 (176) | <0.001 | 73 (219) | 35 (178) | <0.001 | 12 (69) | 0 (27) | >0.10 | 90 (215) | 4 (171) | <0.001 | 96 (181) | 18 (136) | <0.001 |
| Atakouma (2006) | – | – | – | 100 (150) | 89 (150) | <0.05 | – | – | – | – | – | – | – | – | – |
| Briggs (2002) | – | – | – | 96 (473) | 72 (1066) | <0.001 | – | – | – | 74 (120) | 18 (176) | <0.001 | 96 (120) | 79 (176) | <0.001 |
| Burnham (1997) | – | – | – | 42 (126) | 35 (97) | 0.33 | – | – | – | 58 (126) | 31 (97) | <0.001 | 57 (126) | 42 (97) | – |
| Choi (2003) | 60 (132) | 23 (143) | <0.001 | 45 (73) | 36 (28) | 0.5 | 93 (214) | 84 (146) | 0.01 | 49 (214) | 7 (146) | <0.001 | 44 (214) | 19 (146) | <0.001 |
| Chopra (2005) | 90 (64) | 45 (80) | <0.01 | – | – | – | – | – | – | 54 (56) | 35 (80) | <0.05 | – | – | – |
| Degbey (2005) | – | – | – | 64 (330) | 56 (204) | 0.08 | – | – | – | – | – | – | – | – | – |
| Eshaghi (2012) | – | – | – | 71 (100) | 28 (100) | <0.01 | – | – | – | – | – | – | – | – | – |
| FMOH Sudan (2004) | 34 (154) | 20 (35) | 0.16 | 35 (118) | 8 (24) | 0.01 | – | – | – | 42 (269) | 0 (81) | <0.001 | 71 (129) | 34 (29) | <0.001 |
| Gilroy (2004) | – | – | – | – | – | – | – | – | – | – | – | – | 99 (182) | 99 (182) | >0.99 |
| Huicho (2005) | – | – | – | 11 (84) | 26 (35) | <0.05 | 5 (38) | 7 (15) | 0.68 | – | – | – | – | – | – |
| Lee (2001) | 60 (921) | 38 (1462) | <0.001 | 58 (908) | 41 (1447) | <0.001 | – | – | – | – | – | – | – | – | – |
| MOH Viet Nam (2002) | 65 (181) | 36 (39) | 0.001 | 64 (36) | 33 (9) | 0.14 | 5 (39) | 0 (9) | 0.99 | 54 (180) | 3 (38) | <0.01 | 64 (66) | 13 (15) | <0.001 |
| Naimoli (2006) | 68 (242) | 51 (225) | <0.001 | 56 (98) | 17 (89) | <0.001 | 12 (25) | 12 (17) | 0.99 | 40 (231) | 7 (219) | <0.001 | 93 (102) | 49 (95) | <0.001 |
| Pariyo (2005) | 38 (532) | 17 (151) | <0.001 | 54 (414) | 40 (108) | <0.05 | 17 (205) | 4 (46) | <0.05 | 33 (500) | 14 (147) | <0.01 | 68 (476) | 31 (134) | <0.001 |
| Rakha (2013) | – | – | – | 81 (16) | 10 (58) | <0.001 | – | – | – | – | – | – | – | – | – |
| Rehlis (2003) | 45 (163) | 28 (96) | 0.001 | – | – | – | – | – | – | 61 (163) | 50 (96) | 0.09 | 43 (163) | 49 (96) | 0.37 |
| Rehlis (2007) | – | – | – | 67 (126) | 23 (156) | <0.001 | 26 (126) | 18 (156) | 0.11 | 60 (126) | 10 (156) | <0.001 | – | – | – |
| Rowe (2009) | 67 (242) | 32 (111) | <0.001 | 54 (184) | 10 (79) | <0.001 | – | – | – | 5 (184) | 0 (79) | 0.06 | – | – | – |
| Salgado (2002) | 33 (54) | 22 (148) | 0.14 | 50 (18) | 43 (42) | 0.78 | 72 (29) | 69 (71) | 0.81 | 24 (25) | 18 (62) | 0.56 | 35 (23) | 23 (62) | 0.28 |
| Santos (2001) | – | – | – | – | – | – | – | – | – | 63 (166) | 59 (175) | <0.001 | – | – | – |
| Uzochukwu (2008) | 87 (109) | 34 (78) | <0.001 | 82 (44) | 26 (31) | <0.001 | 100 (10) | 13 (8) | <0.001 | – | – | – | 81 (72) | 19 (52) | <0.001 |
| Zaman (2008) | – | – | – | – | – | – | – | – | – | 33 (52) | 4 (53) | 0.003 | – | – | – |
| Zhang (2007) | – | – | – | 94 (146) | 41 (550) | <0.001 | – | – | – | – | – | – | – | – | – |
–Not reported;
¥sample sizes reflect total illness encounters instead of total child encounters.
Comparisons of the pooled effect estimates and number needed to treat for each primary outcome and stratified by baseline performance.
| Outcome | Pooled Relative Risk | Pooled Risk Difference | Number Needed to Treat | |||
| RR | (95% CI) | RD (%) | (95% CI) (%) | NNT | (95% CI) | |
| Illness Classification | 1.93 | (1.66–2.24) | 30.1 | (22.3–37.9) | 4 | 3–5 |
| Higher Baseline | 1.74 | (1.52–2.00) | 28.5 | (14.6–42.4) | 4 | 3–7 |
| Lower Baseline | 2.27 | (1.66–3.11) | 31.1 | (22.3–37.9) | 4 | 3–5 |
| Medications | 1.77 | (1.53–2.06) | 29.7 | (21.3–38.0) | 4 | 3–5 |
| Higher Baseline | 1.42 | (1.22–1.64) | 19.7 | (10.5–28.8) | 6 | 4–10 |
| Lower Baseline | 3.08 | (2.04–4.66) | 41.7 | (26.7–56.6) | 3 | 2–4 |
| Vaccinations | 1.16 | (0.98–1.36) | 10.5 | (2.6–18.3) | 10 | 6–39 |
| Higher Baseline | 1.10 | (1.03–1.19) | 6.7 | (1.9–11.6) | 15 | 7–53 |
| Lower Baseline | 3.45 | (1.48–8.01) | 18.9 | (2.6–35.1) | 6 | 3–39 |
| Nutrition | 3.57 | (2.43–5.25) | 33.8 | (19.8–47.9) | 3 | 3–5 |
| Higher Baseline | 1.74 | (1.29–2.35) | 21.1 | (9.6–32.5) | 5 | 4–11 |
| Lower Baseline | 10.12 | (6.03–16.99) | 45.2 | (23.7–66.7) | 3 | 2–5 |
| Caregiver Instruction | 2.05 | (1.61–2.60) | 34.4 | (16.3–52.5) | 3 | 2–7 |
| Higher Baseline | 1.38 | (1.13–1.70) | 20.1 | (5.2–34.9) | 5 | 3–20 |
| Lower Baseline | 3.76 | (2.30–6.13) | 49.0 | (28.6–69.4) | 3 | 2–4 |
Stratified analyses of IMCI and non-IMCI trained health workers’ performance outcomes with the number of pooled studies before each point estimate.
| Indicator | Classification | Medication | Vaccination | Nutrition | Caregiver Instruction | ||||||||||
| No. | RR (95% CI) | I2 | No. | RR (95% CI) | I2 | No. | RR (95% CI) | I2 | No. | RR (95% CI) | I2 | No. | RR (95% CI) | I2 | |
|
| |||||||||||||||
| Higher | 7 | 1.74 (1.52–2.00) | 68 | 11 | 1.42 (1.22–1.64) | 94 | 5 | 1.10 (1.03–1.19) | 0 | 8 | 1.74 (1.29–2.35) | 88 | 7 | 1.38 (1.13–1.70) | 94 |
| Lower | 7 | 2.27 (1.66–3.11) | 77 | 10 | 3.08 (2.04–4.66) | 76 | 5 | 3.45 (1.49–8.01) | 0 | 6 | 10.12 (6.03–16.99) | 59 | 7 | 3.76 (2.30–6.13) | 82 |
|
| |||||||||||||||
| Higher | 3 | 1.77 (1.29–2.41) | 88 | 5 | 2.04 (1.16–3.59) | 89 | 3 | 1.01 (0.72–1.41) | 0 | 4 | 1.87 (1.16–3.02) | 93 | 2 | 1.97 (1.64–2.38) | 0 |
| Lower | 11 | 2.02 (1.67–2.44) | 77 | 16 | 1.63 (1.42–1.87) | 89 | 7 | 1.27 (0.98–1.63) | 46 | 13 | 5.11 (2.95–8.87) | 91 | 12 | 2.03 (1.57–2.62) | 95 |
|
| |||||||||||||||
| Cross–Sectional | 8 | 1.71 (1.46–2.02) | 59 | 14 | 1.53 (1.32–1.78) | 89 | 8 | 1.14 (0.94–1.38) | 0 | 11 | 3.60 (2.28–5.69) | 92 | 10 | 1.89 (1.39–2.57) | 92 |
| Pre–Post Study | 5 | 2.04 (1.64–2.54) | 78 | 6 | 2.53 (1.74–3.67) | 94 | 2 | 2.13 (0.44–10.29) | 79 | 3 | 3.73 (0.97–14.40) | 89 | 2 | 2.97 (1.66–5.34) | 67 |
| Cluster RCT | 1 | 27.14 (8.82–83.51) | – | 1 | 34.17 (4.91–237.96) | – | – | – | – | 3 | 8.27 (0.72–94.85) | 90 | 2 | 4.90 (0.20–121.23) | 97 |
|
| |||||||||||||||
| Yes | 4 | 2.61 (1.68–4.04) | 88 | 5 | 1.49 (0.91–2.44) | 86 | 4 | 1.62 (0.66–4.00) | 41 | 4 | 6.38 (2.01–20.25) | 95 | 4 | 4.34 (2.21–8.54) | 91 |
| No | 10 | 1.80 (1.56–2.08) | 66 | 16 | 1.85 (1.57–2.19) | 94 | 6 | 1.15 (0.97–1.36) | 23 | 13 | 3.23 (2.04–5.09) | 92 | 10 | 1.54 (1.25–1.89) | 92 |
|
| |||||||||||||||
| ≥11 Days | 9 | 1.96 (1.60–2.39) | 76 | 7 | 2.15 (1.54–3.02) | 84 | 3 | 3.62 (1.15–11.41) | 0 | 8 | 6.05 (2.61–14.02) | 92 | 7 | 2.63 (1.48–4.69) | 96 |
| <11 Days | 5 | 1.91 (1.44–2.52) | 84 | 14 | 1.69 (1.40–2.03) | 94 | 7 | 1.12 (0.99–1.27) | 12 | 9 | 3.00 (1.88–4.80) | 94 | 7 | 1.87 (1.40–2.50) | 87 |
|
| |||||||||||||||
| ≥1 Year | 2 | 1.80 (1.49–2.18) | 25 | 2 | 2.26 (2.05–2.49) | 0 | 1 | 6.80 (0.41–113.89) | – | 2 | 5.70 (0.42–77.82) | 98 | 1 | 5.45 (3.79–7.84) | – |
| <1 Year | 12 | 1.97 (1.65–2.35) | 81 | 19 | 1.66 (1.44–1.90) | 89 | 9 | 1.14 (0.98–1.33) | 20 | 15 | 3.27 (2.22–4.82) | 91 | 13 | 1.83 (1.47–2.28) | 94 |
|
| |||||||||||||||
| ≥1 in 6 Months | 6 | 2.09 (1.57–2.78) | 86 | 8 | 1.91 (1.31–2.80) | 89 | 5 | 1.11 (1.03–1.20) | 0 | 6 | 5.97 (2.26–15.75) | 92 | 5 | 3.18 (1.28–7.88) | 97 |
| <1 in 6 Months | 8 | 1.88 (1.56–2.26) | 69 | 13 | 1.73 (1.44–2.07) | 94 | 5 | 1.84 (0.81–4.19) | 51 | 11 | 2.64 (1.79–3.89) | 91 | 9 | 1.79 (1.37–2.35) | 88 |
|
| |||||||||||||||
| ≥50% Supplies | 7 | 1.84 (1.52–2.23) | 74 | 9 | 1.84 (1.38–2.47) | 85 | 7 | 1.10 (1.02–1.19) | 0 | 7 | 4.21 (2.26–7.86) | 94 | 7 | 2.27 (1.48–3.49) | 91 |
| <50% Supplies | 7 | 2.13 (1.60–2.82) | 83 | 12 | 1.62 (1.39–1.88) | 90 | 3 | 1.44 (0.84–2.44) | 67 | 10 | 3.28 (1.85–5.81) | 91 | 7 | 1.67 (1.30–2.15) | 93 |
|
| |||||||||||||||
| Yes | 5 | 2.02 (1.49–2.75) | 86 | 6 | 2.30 (1.60–3.30) | 90 | 2 | 1.64 (0.74–3.61) | 11 | 6 | 5.66 (2.43–13.21) | 93 | 4 | 2.99 (1.02–8.76) | 97 |
| No/Not Reported | 9 | 1.93 (1.61–2.32) | 70 | 15 | 1.59 (1.32–1.92) | 94 | 8 | 1.12 (0.95–1.31) | 18 | 11 | 3.01 (2.00–4.63) | 91 | 10 | 2.05 (1.57–2.68) | 96 |
|
| |||||||||||||||
| Yes | 7 | 2.15 (1.65–2.80) | 80 | 9 | 1.70 (1.25–2.32) | 94 | 5 | 1.10 (1.02–1.18) | 0 | 8 | 4.08 (2.15–7.74) | 94 | 7 | 2.43 (1.44–4.11) | 95 |
| No/Not Reported | 7 | 1.77 (1.50–2.08) | 68 | 12 | 1.85 (1.51–2.26) | 91 | 5 | 1.92 (1.09–3.41) | 18 | 9 | 3.37 (1.94–5.85) | 92 | 7 | 1.95 (1.31–2.92) | 95 |
|
| |||||||||||||||
| Adjusted Analyses | 8 | 1.91 (1.56–2.34) | 84 | 8 | 2.15 (1.58–2.92) | 85 | 4 | 1.57 (0.69–3.54) | 41 | 9 | 4.90 (2.61–9.23) | 94 | 7 | 2.75 (1.60–4.73) | 97 |
| Blinding | 1 | 1.69 (0.84–3.40) | – | 2 | 2.61 (1.88–3.63) | 0 | – | – | – | 3 | 6.46 (0.69–60.16) | 88 | 1 | 2.07 (1.24–3.46) | – |
| Comparable Baseline | 10 | 2.03 (1.70–2.43) | 85 | 12 | 2.10 (1.65–2.68) | 92 | 6 | 1.30 (0.90–1.87) | 49 | 10 | 3.99 (2.33–6.83) | 94 | 8 | 2.93 (1.75–4.91) | 97 |
| Excl. Grey Lit | 8 | 2.11 (1.67–2.67) | 85 | 12 | 2.23 (1.61–3.08) | 95 | 6 | 1.90 (0.86–4.18) | 48 | 9 | 3.61 (2.10–6.22) | 93 | 7 | 3.06 (1.74–5.38) | 97 |
| Excl. Composite | 10 | 1.96 (1.59–2.40) | 79 | 15 | 2.02 (1.51–2.70) | 94 | 8 | 1.14 (0.94–1.38) | 0 | 16 | 3.35 (2.27–4.94) | 92 | 11 | 1.93 (1.50–2.49) | 96 |
Abbreviations: RR = Pooled relative risk; 95% CI = 95% confidence intervals; HDI = Human Development Index; MCE = Multi-Country Evaluation; C-RCT = cluster randomized controlled trial, Excl. Grey Lit = excluding grey literature; Excl. Composite = excluding composite proportions based on illness encounters instead of child encounters; –Not reported.
Figure 2Forest plots showing pooled point estimates for various outcomes stratified by baseline performance.
(a) Illness classification stratified by baseline performance. (b) Medications stratified by baseline performance. (c) Vaccinations stratified by baseline performance.
Figure 3Forest plots showing pooled point estimates for counseling outcomes stratified by baseline performance.
(a) Nutrition stratified by baseline performance. (b) Instruction stratified by baseline performance.